Ibrutinib in B-cell lymphoma: single fighter might be enough?
Abstract Background In recent years, the B cell receptor (BCR) signaling pathway has become a “hot point” because it plays a critical role in B-cell proliferation and function. Bruton’s tyrosine kinase (BTK) is overexpressed in many subtypes of B-cell lymphoma as a downstream kinase in the BCR signa...
Guardat en:
| Autors principals: | , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BMC
2020-09-01
|
| Col·lecció: | Cancer Cell International |
| Matèries: | |
| Accés en línia: | http://link.springer.com/article/10.1186/s12935-020-01518-y |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|